Pivotal trial of Nitric Oxide-Inhalation (NO) in the patients with Mycobacterium Abscessus Complex (MABSC).
Phase of Trial: Phase III
Latest Information Update: 13 Aug 2018
At a glance
- Drugs Nitric oxide (Primary)
- Indications Mycobacterium avium complex infections
- Focus Registrational; Therapeutic Use
- Sponsors AIT
- 13 Aug 2018 According to an AIT media release, this trial is expected to begin in late 2019.
- 14 Jun 2018 According to an AIT media release, the company anticipates meeting with the FDA to discuss regarding the design of this pivotal study.
- 24 Jan 2018 Planned initiation date changed from 1 Jul 2017 to 1 Jul 2018.